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Abstract
Purpose The purpose of the study was to determine if a
positive association exists between arterial vessel wall
thickness and generalized osteoarthritis (OA). Our hypoth-
esis is that generalized OA is another facet of the metabolic
syndrome.
Materials and methods The medical ethical review board of
our institution approved the study. Written informed consent
was obtained from each patient prior to the study. Magnetic
resonance (MR) images of the knee were obtained in 42
patients who had been diagnosed with generalized OA at
multiple joint sites. Another 27 MR images of the knee were
obtained from a matched normal (non-OA) reference
population. Vessel wall thickness of the popliteal artery
was quantitatively measured by dedicated software. Linear
regression models were used to investigate the association
between vessel wall thickness and generalized OA. Adjust-
ments were made for age, sex, and body mass index (BMI).
Confidence intervals (CI) were computed at the 95% level
and a significance level of α=0.05 was used.
Results Patients in the generalized OA population had a
significant higher average vessel wall thickness than
persons from the normal reference population (p ≤ α),
even when correction was made for sex, age, and BMI. The
average vessel wall thickness of the popliteal artery was
1.09 mm in patients with generalized OA, and 0.96 mm in
the matched normal reference population.
Conclusion The association found between increased pop-
liteal artery vessel wall thickness and generalized osteoar-
thritis suggests that generalized OA might be another facet
of the metabolic syndrome.
Keywords Osteoarthritis . Popliteal artery .Metabolic
syndrome .Magnetic resonance imaging
Introduction
Osteoarthritis (OA) is a chronic, progressive joint disease,
leading to pain and loss of function in a considerable
proportion of patients, with great impact and consequences
in the ageing population of the industrialized world [1].
Known risk factors for hip and knee OA are age, female
gender, and obesity [2]. Paradoxically, obesity is also a risk
factor for hand OA [3–6]. Whilst the increased joint stress
accompanying obesity may explain the strong linkage
between obesity and knee and hip OA, it does not explain
why hand OA should be linked with obesity. Furthermore,
OA is also associated with an increase in comorbid risk
factors including cardiovascular disease and hypertension
[7–9]. Since obesity, hypertension, and cardiovascular
disease are part of the metabolic syndrome one might
wonder if OA is another aspect of the metabolic syndrome.
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The metabolic syndrome is the concurrence in an
individual of multiple metabolic abnormalities associated
with atherosclerotic cardiovascular disease. It includes a
combination of risk determinants including atherogenic
dyslipidemia, elevated blood pressure, elevated blood
glucose, a prothrombotic state, and a proinflammatory state
[10–12]. Recent guidelines propose that the finding of any
three of five easily recognized components (abdominal
obesity, elevated triglycerides, reduced high-density lipo-
protein (HDL), elevated blood pressure, and elevated blood
glucose) are sufficient for a diagnosis of metabolic
syndrome in clinical practice [12,13]. Furthermore, indi-
viduals with metabolic syndrome have a higher frequency
of carotid plaques and a higher vessel wall thickness of the
common carotid artery [14,15].
Therefore, the hypothesis was that a positive association
between arterial vessel wall thickness and generalized OA
might suggest that generalized OA is indeed part of the
metabolic syndrome. In the present study we semi-
automatically assessed popliteal artery vessel wall thickness
in a normal reference population and in 42 patients with
generalized OA.
Patients and methods
Patients
The present study is part of the ongoing GARP (Genetics,
Osteoarthritis and Progression) study [16]. The primary
goal of the GARP study is the identification of genetic
susceptibility determinants to OA and disease progression
in middle-aged sib pairs with OA at multiple joint sites.
Patients were required to have symptomatic OA in at least
two or more of the following joint sites: hands, spine
(cervical or lumbar), knees or hips. MR image sets of the
knee were obtained at study entry [17]. Patients included in
the present study were the first 42 consecutive patients from
the GARP progression study. The normal reference popula-
tion consists of volunteers with a sex and age distribution
matched to the GARP population. To be included partic-
ipants had to have minimal radiological spine and radiolog-
ical hand OA, no clinical signs of OA, like joint pain or
stiffness, and no signs of OA as assessed by physical
examination in the hands, hips, spine, and knees. During
physical examination, the presence of knee joint effusion,
range of motion, malalignment, and joint pain on movement
were assessed. Furthermore, they had to have no history of
trauma to the knees or familial predisposition to OA, and
grade 0 on the Kellgren–Lawrence scale on the knee and hip
X-rays. Complete written informed consent was obtained
from each patient prior to the study. The medical ethical
review board of our institution approved the study.
MR acquisition
For the GARP study, knees were imaged using a transmit-
receive 4-channel knee coil in a 1.5T superconducting
magnet (Philips Medical Systems, Best, the Netherlands).
For the retrospective analysis of the current study we
selected one sequence to assess the wall of the popliteal
artery. We used a fat-suppressed dual turbo spin echo
sequence (TR 2,500; TE 7.1/40; NEX 2; 2-mm slice
thickness; no gap; 180-mm field of view; 256 × 256
acquisition matrix, 62 slices) to assess the vessel wall
thickness of the popliteal artery.
Semi-automatic vessel wall thickness quantification
We analyzed all of the images using the VesselMASS
software package developed at our institution [18]. This
software package allows the semi-automated detection of
the luminal and outer wall boundaries of the vessel wall
from MR images, and the subsequent derivation of various
quantitative parameters describing the vessel wall (Fig. 1).
The VesselMass software package has demonstrated excel-
lent agreement between automatic and manual area meas-
urements for the lumen and outer vessel wall contour. We
calculated the vessel wall thickness by subtracting the
luminal area from the outer contour area. The average
vessel wall thickness was calculated by averaging the
vessel wall thickness of all slices [18].
Statistical analysis
The difference in arterial vessel wall thickness between OA
patients and the normal reference population was calculated
by linear regression models in SPSS for Windows, version
12.0 (SPSS, Chicago, IL, USA). Adjustments were made
for age, sex, and body mass index (BMI). Confidence
intervals (CI) were computed at the 95% level and a
significance level of α=0.05 was used.
Results
The basic characteristics of the 42 patients with generalized
OA and the 27 controls from the normal reference
population are shown in Table 1. Patients in the generalized
OA population had a higher average vessel wall thickness
than persons from the normal reference population (p ≤ α,
CI: 0.9–2.2), when adjustments were made for sex, age, and
BMI. We found a positive association between average
vessel wall thickness and age (p ≤ α, CI: 0.2–0.6); older
people having a significantly higher average vessel wall
thickness in both the generalized OA and in the normal
reference populations. Patients with generalized OA had a
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slightly higher BMI than the normal reference population;
however, this was not significant (p=0.63 CI: −0.4 to 0.2).
Patients with generalized OA also showed a slightly
decreased hip–waist ratio compared with the normal
reference population. However, this too was not significant
(p=0.32, CI:−0.3 to 0.4).
Discussion
In the present study, patients with generalized OA had a
significantly higher average popliteal artery wall thickness
than persons from the normal reference population, even
when correction was made for confounders including sex,
age, and BMI. Thus, we confirmed an association between
a possible feature of the metabolic syndrome, that is, an
increased popliteal artery wall thickness, and generalized
OA. This is clearly of major significance in the etiology and
management of generalized OA. However, caution must be
exercised for whilst it has been demonstrated that individ-
uals with metabolic syndrome have a higher frequency of
carotid plaques and a higher intima media thickness of the
common carotid artery [14, 15], data on popliteal artery
thickness have not been presented previously and require
confirmation. Furthermore, it is not known whether the
increased wall thickness of the carotid artery is a localized
or generalized medium-sized artery phenomenon. Nonethe-
less, the present data do suggest that arterial thickening
might be present in generalized OA and hence may be
another sign of the metabolic syndrome. Further, as
expected, we confirmed a positive association between
average popliteal artery vessel wall thickness and age both
in patients with generalized OA and in the normal reference
population, and this relationship has been described
previously [19]. This too suggests that the data presented
here might be accurate and therefore the postulate reason-
able.
Recently, two hypotheses were advanced that contribute
to a possible causal relationship between obesity-associated
metabolic changes and osteoarthritis. The first postulates
that obesity-associated atherosclerosis in the subchondral
bone might play a role in the progression of osteoarthritis
[20]. In osteoarthritis the subchondral bone might be
affected by microvascular changes in both the arterial as
well as the venous side of the vascular circulation [21]
resulting in episodically reduced blood flow through the
small vessels in the subchondral bone and finally leading to
subchondral ischemia. Vascular disease in subchondral
bone may also explain fluctuation in subchondral bone
marrow edema lesions, recently reported on MR images in
OA patients [22], as it may resemble episodes of avascular
necrosis. The link between osteoarthritis and atherosclerosis
is supported by epidemiological studies. A higher preva-
lence of cardiovascular risk factors, like hypertension and
Normal reference population OA population
Number of patients 27 42
Age, years, median (range) 59 (44–75) 58 (46–75)
Female sex (%) 20 (74) 35 (83)
Body mass index (kg/m2), median (range) 25 (20–32) 27 (21–35)
Vessel wall thickness (mm), median (range) 0.96 (0.71–1.10) 1.09 (0.96–1.62)
Hip–waist ratio, median (range) 1.20 (0.95–1.44) 1.17 (1.03–1.37)
Generalized OA, n (%) 0 (0) 42 (100)
Symptomatic knee OA, n (%)a 0 (0) 16 (38)
Table 1 Patient characteristics
OA = osteoarthritis
a Defined as pain or stiffness on
most days of the month prior to
study entry, in combination with
osteophytes on radiographs
Fig. 1 a Axial fat-suppressed
spin echo image of the knee
after semi-automatic vessel wall
thickness quantification in a
patient with generalized OA.
Note the osteophytes at the
femoral condyle. b Detail
of the semi-automatic vessel
wall thickness quantification of
the luminal and outer wall
boundaries of the
vessel wall
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diabetes type 2, and cardiovascular comorbidity have been
suggested in osteoarthritis [23,24]. Several studies indicated
that cardiovascular mortality may be linked to the severity
and extent of osteoarthritis [25,26]. In a Finnish cohort it
was demonstrated that in men, osteoarthritis in any finger
joint predicted eventual cardiovascular death [26].
The second hypothesis postulates that the metabolic
changes in the striated muscle induced by the interaction of
insulin resistance and systemic inflammation in obese
subjects with metabolic syndrome might lead to fatigue
and muscle weakness, which negatively influences the
balance between damage and repair mechanisms leading to
osteoarthritis [27].
The suggestion that OA is associated, or is part of, the
metabolic syndrome may be of clinical relevance and an
important finding as it demonstrates another potential
etiological factor in the development of more effective
treatments to inhibit the progression of OA.
The present study has limitations. First, we associated an
indirect sign of the metabolic syndrome, average vessel wall
thickness of the popliteal artery, with OA. With the exception
of hip–waist ratios, the other direct parameters of the
metabolic syndrome (elevated triglycerides, reduced high-
density lipoprotein (HDL), elevated blood pressure, and
elevated blood glucose) were not available in the patients
studied. Blood samples and blood pressure were taken and
recorded, but patients were using medication as necessary.
Therefore, standard laboratory/clinical guidelines used to
define metabolic syndrome are not used as a gold standard.
Second, this was a retrospective pilot study and the findings
will need to be confirmed using a larger study population.
Third, we have not addressed the apparent paradox between
the fact that whilst we found no association between vessel
wall thickness and obesity, a positive association between
OA and vessel wall thickness was found. However, a definite
association exists between OA and obesity and the linkage
between the metabolic syndrome is not simply a raised BMI,
it is rather associated with intra-abdominal obesity. Hip–
waist ratios were available in the present study and showed a
trend supporting this concept. A fourth limitation is the
absence of an analysis of other potential cofounders such as
diet, physical activity, and pain scores. It is possible that
patients with generalized OA experienced pain with move-
ment and thus avoid participation in regular physical activity,
which may explain in part the vascular pathology. Patients in
the generalized OA group did report having more pain in
their joints than subjects in the normal reference control
group. Lastly, the popliteal artery was analyzed as opposed
to the carotid artery. This was a matter of expediency, as the
MR imaging available to review included this vessel and it
was not considered appropriate to recall patients in order to
study either their carotid arteries or thoracic aorta in this
retrospective study.
In conclusion, the present study demonstrates a positive
association between popliteal artery vessel wall thickness
and generalized osteoarthritis, suggesting that generalized
OA might also be part of the metabolic syndrome. If this is
the case, osteoarthritis might be treated by treating the
metabolic syndrome.
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